OraSure Technologies (OSUR)
(Delayed Data from NSDQ)
$5.49 USD
+0.01 (0.18%)
Updated May 3, 2024 04:00 PM ET
After-Market: $5.48 -0.01 (-0.18%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OSUR 5.49 +0.01(0.18%)
Will OSUR be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for OSUR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OSUR
Insulet (PODD) Surpasses Q4 Earnings and Revenue Estimates
Baxter International (BAX) Tops Q4 Earnings and Revenue Estimates
OSUR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Abbott (ABT) Q4 Earnings Match Estimates
Zacks.com featured highlights Otter Tail, OraSure, BioMarin and Regeneron
Buy These 4 Low-Beta Stocks to Counter Market Volatility
Other News for OSUR
Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth
OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th
Wall Street Favorites: 3 Under-$10 Stocks With Strong Buy Ratings for April 2024Â
OraSure reports cybersecurity breach, says incident has been contained
Top buy-rated stocks and sell-rated stocks within Health Care - Citi